Delivery Order SPE2DB20D3303-SPE2DB24FA2RN
Award Date
9/3/24
Potential Completion Date
9/4/24
Potential Value
$15K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. The contract is for the supply of 4,563,940,971 units of the GARDASIL 9 vaccine syringe (0.5 mL) with a ceiling value of $38,099.36. The delivery order was issued under an existing indefinite delivery contract (IDC) with a potential value of $999,999,999.00 held by AmerisourceBergen...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $5,242.38, is for the delivery of 4,568,116,064 units of the GARDASIL 9 vaccine syringe (0.5 mL). The contract has an ultimate completion date of May 5, 2025 and was awarded on May 2, 2025. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,927,167 units of the GARDASIL 9 vaccine syringe (0.5 mL), with a ceiling value of $17,718.03 and a period of performance through April 16, 2025. The contract is not set aside and was awarded on April 15, 2025. AmerisourceBergen Drug Corp holds a significant...
This is a firm-fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,629.01, is for the delivery of 4,568,051,548 units of the GARDASIL 9 SYRINGE 0.5ML vaccine. The contract has an ultimate completion date of April 29, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen Drug Corp with...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order contract valued at $9,761.55 to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the supply of 4,565,684,229 units of GARDASIL 9 vaccine syringes (0.5 mL) with a completion date of September 5, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and Amerisourcebergen, valued at up to $999,999,999 through December 2025,...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of GARDASIL 9 SYRINGE 0.5ML, a vaccine product, with a ceiling value of $5,694.12 and a completion date of July 2, 2024. The contract is not associated with a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a $32,096.81 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of GARDASIL 9 vaccine syringes. The contract has a period of performance through February 4, 2025 and is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999. The IDC serves as a primary vehicle for AmerisourceBergen to provide a comprehensive range of pharmaceutical products and...
This is a $92,568.81 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of GARDASIL 9 SYRINGE 10S, a vaccine product, with a completion date of January 15, 2025. The order is part of AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, the prime contractor. The contract is for the supply of GARDASIL 9 vaccine syringes, a pharmaceutical product. The total ceiling value of the contract is $7,642.41, with an ultimate completion date of April 2, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to AmerisourceBergen Drug Corp, with a potential...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of GARDASIL 9 SYRINGE 0.5ML, a vaccine product, with a ceiling value of $1,747.46 and a period of performance through April 18, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that AmerisourceBergen holds with the DLA...